Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands out in the healthcare sector, particularly within the drug manufacturing industry, for its focus on both specialty and generic pharmaceuticals. Headquartered in Rancho Cucamonga, California, Amphastar develops a broad range of products, including injectable, inhalation, and intranasal treatments, serving markets in the United States, China, and France.

With a market capitalization of $1.28 billion, Amphastar’s current stock price is $27.55. Over the past year, the stock has traded between $20.62 and $32.29, indicating a robust performance relative to its peers. While the stock experienced a minor dip of 0.03% recently, the company’s future potential remains compelling,…